Ledger.Open graph →
SEC Form D · filed August 7, 2017

Q BioMed Inc

Offering
$3.1M
Sold
$3.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Paul King · Luxembourg City, LuxembourgExec · DirectorEvelyn K. Echevaria · Fort Mill, SCExec · DirectorBenjamin Jacobson, Iii · Austin, TXExec · DirectorStella H. Amar-Cohen · Montreal, Quebec, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗